Predictive factors for all-cause mortality in the hospitalized elderly subject: The importance of arrhythmia

Atherosclerosis

Volumn 207, Issue 2, 2009, Pages 507-513

  Vesin, Claire ^a   Protogerou, Athanase D ^b   Lieber, Ari ^a   Safar, Hélène ^c   Iaria, Pierre ^a   Ducimetière, Pierre ^d   Safar, Michel E ^a   Blacher, Jacques ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF ATHENS   (Greece)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d HÔPITAL PAUL BROUSSE   (France)

Author keywords

Arrhythmia; Elderly; Risk factors for mortality

Indexed keywords

ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELDERLY CARE; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT ATRIUM; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA;

AGE FACTORS; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; ATRIAL FUNCTION, LEFT; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HEART ATRIA; HOSPITAL MORTALITY; HUMANS; INPATIENTS; KAPLAN-MEIERS ESTIMATE; MALE; PARIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 70549097980     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.035     Document Type: Article

References (38)

1. Meaume S., Benetos A., Henry O.F., Rudnichi A., and Safar M.E. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 21 (2001) 2046-2050
2. Fried L.P., Kronmal R.A., Newman A.B., et al. Risk factors for 5-year mortality in older adults. The cardiovascular health study. JAMA 279 (1998) 585-592
3. Weverling-Rijnsburger A.W.E., Blauw G.J., Lagaay M., et al. Total cholesterol and risk of mortality in the oldest old. Lancet 350 (1997) 1119-1123
4. Protogerou A.D., Safar M.E., Iaria P., et al. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 50 (2007) 1-9
5. Sorlie P.D., Garcia-Palmieri M.R., Castillo-Staab M.I., et al. The relation of antemortem factors to atherosclerosis at autopsy. The Puerto Rico Heart Health Program. Am J Pathol 103 (1981) 345-352
6. Benjamin E.J., Wolf P.A., D'Agostino R.B., et al. Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation 98 (1998) 946-952
7. Kannel W.B., Wolf P.A., Benjamin E.J., and Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 8A (1998) 2N-9N
8. de Ruijter W., Westendorp R.G.J., Macfarlane P.W., et al. The routine electrocardiogram for cardiovascular risk stratification in old age: The Leiden 85-plus Study. J Am Geriatr Soc 55 (2007) 872-877
9. Wyse D.G., Waldo A.L., DiMarco J.P., et al. Atrial fibrillation follow-up investigation of rhythm management (AFFIRM) investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
10. Vidaillet H.J. Rate control vs. rhythm control in the management of atrial fibrillation in eledrly persons. Am J Geriatr Cardiol 14 2 (2005) 73-78
11. World Health Organisation. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation. Part I. Diagnosis and classification of diabetes mellitus (1999), World Health Organisation, Geneva
12. Gotto A.M. Cholesterol management in theory and practice. Circulation 96 (1997) 4424-4430
13. Guidelines Subcommittee. 1999 World Health Organisation-International Society of hypertension guidelines for the management of hypertension. J Hypertens 17 (1999) 151-183
14. Furberg C.D., Manolio T.A., Psaty B.M., et al. Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Am J Cardiol 69 (1992) 1329-1335
15. Smulyan H., Sheehe P.R., and Safar M.E. A preliminary evaluation of the mean arterial pressure as measured by Cuff Oscillometry. Am J Hypertens 21 2 (2008) 166-171
16. Sahn D.J., De Maria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation 58 (1978) 1072-1083
17. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55 (1977) 613-618
18. Appleton C.P., Hatle L.K., and Popp R.L. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 12 August (2) (1988) 426-440
19. Pannier B., Brunel P., El Aroussy W., Lacolley P., and Safar M.E. Pulse pressure and echographic findings in essential hypertension. J Hypertens 7 (1989) 127-132
20. Asmar R., Benetos A., Toupouchian J., et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 26 (1995) 485-490
21. Laurent S., Cockroft J., Van Bortel L., et al. European network for non-invasive investigation of large arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27 (2006) 2588-2605
22. Van Bortel. Is arterial stiffness ready for daily clinical practice?. J Hypertens 24 (2006) 281-283
23. Touboul P.J., Prati P., Scarabin P.Y., et al. Use of monitoring software to improve the measurements of carotid wall thickness by B-mode imaging. J Hypertens 10 Suppl. 5 (1992) S37-S41
24. Tartière J.M., Kesri L., Safar H., et al. Association between pulse pressure, carotid intima-media thickness and carotid and/or iliofemoral plaque in hypertensive patients. J Hum Hypertens 18 (2004) 325-331
25. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 285 (2001) 2370-2375
26. Lake F.R., Cullen K.J., Ce Kierk N.H., McCall M.G., and Rosman D.L. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med 19 (1989) 321-326
27. Phillips S.J., Whisnant J.P., Wm O.F., and Frye R.L. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 65 (1990) 344-359
28. Furberg C.D., Psaty B.M., Manolio T.A., et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74 (1994) 236-241
29. Mitchell G.F., Vasan R.S., Keyes M.J., et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA 297 (2007) 709-715
30. Psaty B.M., Manolio T.A., Kuller L.H., et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96 (1997) 2455-2461
31. Vaziri S.M., Larson M.G., Benjamin E.J., and Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation: the Framingham Heart Study. Circulation 89 (1994) 724-730
32. Gardin J.M., Arnold A., Gottdiener J.S., et al. Left ventricular mass in the elderly: the Cardiovascular Health Study. Hypertension 29 (1997) 1095-1103
33. Tsang T.S., Gersh B.J., Appleton C.P., et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 40 (2002) 1636-1644
34. Casaclang-Verzosa G., Gersh B.J., and Tsang T.S.M. Structural and functional remodeling of the left atrium. J Am Coll Cardiol 51 (2008) 1-11
35. Aboaf A.P., and Wolf P.S. Paroxysmal atrial fibrillation. Arch Intern Med 156 (1996) 362-367
36. Milliez P., DeAngelis N., Rucker-Martin C., et al. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J 26 (2005) 2193-2199
37. Nehme J.A., Lacolley P., Labat C., et al. Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure. J Mol Cell Cardiol 39 (2005) 511-519
38. Nehme J., Mercier N., Labat C., et al. Differences between cardiac and arterial fibrosis and stiffness in aldosterone-salt rats: effect of eplerenone. JRAAS 7 (2006) 31-39